Literature DB >> 12004318

Coccidioidomycosis: case report and update on diagnosis and management.

Amy Kim1, Sareeta Singh Parker.   

Abstract

Coccidioidomycosis is a disease known for its endemicity to the Southwest United States. However, given the current trends of more frequent tourist and business travel, an increasing number of coccidioidomycosis infections are being seen in patients in other areas of the United States. Because the majority of patients with disseminated disease experience cutaneous manifestations, dermatologists can be of primary importance in the diagnosis of this disease. We report a case of coccidioidomycosis manifesting as granulomatous cutaneous nodules on the face of an otherwise healthy white man. We attempt to provide an update on the diagnosis, management, and treatment of patients who present with cutaneous lesions caused by coccidioidomycosis infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12004318     DOI: 10.1067/mjd.2002.119561

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Dermatologic Infectious Diseases in International Travelers.

Authors:  Mary E. Wilson; Lin H. Chen
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 2.  Primary Cutaneous Coccidioidomycosis: An Update.

Authors:  Irving Llibran Reyna-Rodríguez; Jorge Ocampo-Candiani; Sonia Chavez-Alvarez
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 3.  Primary Cutaneous Coccidioidomycosis in an Italian Nun Working in South America and Review of Published Literature.

Authors:  A M Tortorano; G Carminati; A Tosoni; K Tintelnot
Journal:  Mycopathologia       Date:  2015-05-03       Impact factor: 2.574

4.  [Coccidioidomycosis. Two case reports with discussion of current diagnostic and therapeutic issues].

Authors:  F Meier; K Tintelnot; G Metzler; S Schmidt; B Walker; C Scherwitz
Journal:  Hautarzt       Date:  2004-12       Impact factor: 0.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.